Watermark Blog
Blog Home All Blogs
Search all posts for:   

 

View all (146) posts »
 

New Keynote, Dr. Melanie Matheu at Women in Health and Life Sciences Summit

Posted By Administration, Tuesday, February 19, 2019
Updated: Tuesday, February 19, 2019

AFTERNOON KEYNOTE FEATURE: Dr. Melanie Matheu

Friday | March 8 | 9 a.m. - 5 p.m. | Nevro | Redwood City | RSVP TODAY

We continue to bring the foremost thought-leaders and innovators to our events and conferences. Our inaugural Women in Health and Life Sciences Summit is no different. Our afternoon fireside keynote is with Dr. Melanie Matheu, CEO and Co-founder of Prellis Biologics, who will share her vision to eliminate the need for organ donor lists, and the challenges she has faced as a woman in this industry (but it hasn't stopped her from from developing a background in Immunology, Chemistry, Physiology, & Biophysics, just to name a few.

One of the fastest rising CEOs in the Bay Area, Dr. Matheu and her company are creating fully vascularized human tissues and organs for transplantation. Her realization that the tiny blood vessels necessary for creating human organs could be replicated using the laser technology at the center of her PhD thesis work, led to development of the blended engineering and biology approach Prellis is using to solve the human organ shortage. Dr. Matheu is an expert in laser-based imaging of the immune system and developed Prellis' platform technology. She brings her multi-disciplinary experience in specialized laser microscopy, cell biology, physiology, and biophysics to address the unsolved biomedical challenge of rapid 3D printing of large, vascularized tissues.

Check out all the speakers, including Watermark exclusive development and leadership workshops. And as always, thank you to our host and sponsor, Nevro.

Registration is open to everyone however a limited number of registrations will be available. Secure your space, and RSVP TODAY.

Tags:  Health and Life Science  HLSS  Nevro  Watermark  WeAreWatermark 

Share |
Permalink | Comments (0)